Literature DB >> 23704826

Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors.

Iago Rodríguez-Lago1, Cristina Carretero, Maite Herráiz, José C Subtil, Maite Betés, Macarena Rodríguez-Fraile, Jesús J Sola, José I Bilbao, Miguel Muñoz-Navas, Bruno Sangro.   

Abstract

AIM: To evaluate the long-term natural history of the gastroduodenal lesions secondary to extrahepatic embolization with Ytrium 90 (⁹⁰Y) spheres.
METHODS: From September 2003 to January 2012, 379 procedures of liver radioembolization (RE) using resin microspheres loaded with ⁹⁰Y were performed in our center. We have retrospectively compiled the data from 379 RE procedures performed in our center. We report a comprehensive clinical, analytical, endoscopic and histologic long-term follow-up of a series of patients who developed gastroduodenal lesions after the treatment.
RESULTS: Six patients (1.5%) developed gastrointestinal symptoms and had gastrointestinal lesions as shown by upper endoscopy in the next 12 wk after RE. The mean time between RE and the appearance of symptoms was 5 wk. Only one patient required endoscopic and surgical treatment. The incidence of gastrointestinal ulcerations was 3.75% (3/80) when only planar images were used for the pre-treatment evaluation. It was reduced to 1% (3/299) when single-photon emission computed tomography (SPECT) images were also performed. The symptoms that lasted for a longer time were nausea and vomiting, until 25 mo after the treatment.
CONCLUSION: All patients were free from severe symptoms at the end of follow-up. The routine use of SPECT has decreased the incidence of gastrointestinal lesions due to unintended deployment of ⁹⁰Y particles.

Entities:  

Keywords:  Gastroduodenal ulcer; Liver; Liver neoplasms; Radioembolization; Single-photon emission computed tomography

Mesh:

Substances:

Year:  2013        PMID: 23704826      PMCID: PMC3660818          DOI: 10.3748/wjg.v19.i19.2935

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Radioembolization for the treatment of liver tumors general principles.

Authors:  Andrew Kennedy; Douglas Coldwell; Bruno Sangro; Harpreet Wasan; Riad Salem
Journal:  Am J Clin Oncol       Date:  2012-02       Impact factor: 2.339

2.  A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.

Authors:  R J Lewandowski; L M Kulik; A Riaz; S Senthilnathan; M F Mulcahy; R K Ryu; S M Ibrahim; K T Sato; T Baker; F H Miller; R Omary; M Abecassis; R Salem
Journal:  Am J Transplant       Date:  2009-06-22       Impact factor: 8.086

Review 3.  Radioembolization for hepatocellular carcinoma.

Authors:  Bruno Sangro; Mercedes Iñarrairaegui; Jose I Bilbao
Journal:  J Hepatol       Date:  2011-08-02       Impact factor: 25.083

4.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

5.  Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Authors:  David A Kooby; Vasili Egnatashvili; Swetha Srinivasan; Abbas Chamsuddin; Keith A Delman; John Kauh; Charles A Staley; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2009-12-21       Impact factor: 3.464

6.  Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.

Authors:  T W Leung; W Y Lau; S K Ho; S C Ward; J H Chow; M S Chan; C Metreweli; P J Johnson; A K Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

7.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

Authors:  Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Bassel Atassi; Robert K Ryu; Vanessa L Gates; Albert A Nemcek; Omar Barakat; Al Benson; Robert Mandal; Mark Talamonti; Ching-Yee O Wong; Frank H Miller; Steven B Newman; John M Shaw; Kenneth G Thurston; Reed A Omary; Riad Salem
Journal:  Radiology       Date:  2008-03-18       Impact factor: 11.105

8.  Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.

Authors:  Brian I Carr
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?

Authors:  R T Hoffmann; T F Jakobs; C H Kubisch; H J Stemmler; C Trumm; K Tatsch; T K Helmberger; M F Reiser
Journal:  Eur J Radiol       Date:  2009-03-09       Impact factor: 3.528

10.  Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.

Authors:  Andrew S Kennedy; Patrick McNeillie; William A Dezarn; Charles Nutting; Bruno Sangro; Dan Wertman; Michael Garafalo; David Liu; Douglas Coldwell; Michael Savin; Tobias Jakobs; Steven Rose; Richard Warner; Dennis Carter; Stephen Sapareto; Subir Nag; Seza Gulec; Allison Calkins; Vanessa L Gates; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-20       Impact factor: 7.038

View more
  5 in total

Review 1.  Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.

Authors:  Lynn Jeanette Savic; Julius Chapiro; Jean-François H Geschwind
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

Review 2.  Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Eric A Wang; Scott R Broadwell; Ross J Bellavia; Jeff P Stein
Journal:  J Gastrointest Oncol       Date:  2017-04

3.  International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.

Authors:  Hugo Levillain; Oreste Bagni; Christophe M Deroose; Arnaud Dieudonné; Silvano Gnesin; Oliver S Grosser; S Cheenu Kappadath; Andrew Kennedy; Nima Kokabi; David M Liu; David C Madoff; Armeen Mahvash; Antonio Martinez de la Cuesta; David C E Ng; Philipp M Paprottka; Cinzia Pettinato; Macarena Rodríguez-Fraile; Riad Salem; Bruno Sangro; Lidia Strigari; Daniel Y Sze; Berlinda J de Wit van der Veen; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-12       Impact factor: 9.236

4.  Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

Authors:  Verónica Morán; Elena Prieto; Lidia Sancho; Macarena Rodríguez-Fraile; Leticia Soria; Arantxa Zubiria; Josep M Martí-Climent
Journal:  EJNMMI Phys       Date:  2020-12-07

5.  Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?

Authors:  Jens M Theysohn; Marcus Ruhlmann; Stefan Müller; Alexander Dechene; Jan Best; Johannes Haubold; Lale Umutlu; Guido Gerken; Andreas Bockisch; Thomas C Lauenstein
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.